Early-stage clinical trials are a challenge for all of those involved. Patient safety is our utmost priority, and we ensure this through a professionally trained study team and in an environment with state-of-the-art infrastructure. In addition, sponsors expect rapid recruitment and high data quality. We are convinced that these objectives can be better achieved through an alliance of strongly performing phase I units.


Number of patients treated per type of cancer in 2015

g_cancer_patients*All numerical data is in reference to 2015. „Treated“ refers to all antineoplastic approaches. Actual numbers are likely to be higher due to constant growth of cooperating private practice oncologist network.

ECT.Net Background

At the end of 2014, the ECTUs of the University Cancer Centers in Dresden, Munich and Wuerzburg as well the ECTU of the Cellex Patient Treatment GmbH in Cologne, decided to establish the Early Clinical Trial Network in close cooperation with the GWT-TUD GmbH.


Service for Sponsors and CROs:

  • Single central contact point
  • One contract for multiple sites
  • Rapid feasibility process
  • Site project management
  • Access to more than 15.000 cancer patients each year
  • Performance reporting
  • Consulting in protocol design

Service for Academic Partners:

  • Active sales & promotion
  • Budget calculation
  • Contract & project management
  • Risk management
  • Performance reporting
nach oben